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Edited by Robert BaroukiAbstract Lithium impairs the appearance of the characteristic
morphology of brown adipocytes and downregulates the expres-
sion of marker genes of brown adipocyte diﬀerentiation. These
eﬀects are dose-dependent and are more pronounced when expo-
sure of preadipocytes to lithium is initiated at early stages of dif-
ferentiation. Although lithium reduces the expression of genes
common to both white and brown adipocytes [fatty acid binding
protein aP2 (aP2/FABP) or peroxisome proliferating activated
receptor c], genes expressed diﬀerentially in brown adipocytes,
i.e., uncoupling protein 1, PPAR gamma coactivator-1a, and
peroxisome proliferating activated receptor a, are particularly
sensitive to lithium treatment-dependent downregulation. Brown
adipocytes appear as preferential targets of the inhibitory action
of lithium on adipocyte diﬀerentiation.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Lithium is currently used as an eﬃcient primary therapy for
bipolar disorder. However, lithium therapy in humans is asso-
ciated with several side eﬀects, in particular increased weight
gain. Although behavioural changes associated with lithium
treatment can contribute to this eﬀect, several lines of evidence
have pointed to a direct action of lithium on metabolism as
being responsible for increased fat accumulation in lithium-
treated patients [1,2].
Lithium acts through several molecular mechanisms, the
most relevant being inositol depletion due to inhibition of ino-
sitol monophospthatase, inhibition of other phosphomonoes-
terases, and inhibition of glycogen synthase kinase (GSK-3)
[3]. GSK3b is a negative regulator of the Wnt signalling path-
way. Wnts are a family of secreted glycoproteins involved in
embryonic development and other cellular processes. The
Wnt signalling pathway involves the interaction of Wnt with
the Frizzled receptor at the cell surface and the subsequent
inhibition of GSK-3b, leading, through stabilisation of b-cate-
nin, to transcriptional activation of target genes. Lithium mim-Abbreviations: UCP-1, uncoupling protein 1; CO, cytochrome c oxi-
dase; PPAR, peroxisome proliferating activated receptor; PGC-1a,
PPAR gamma coactivator-1a
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adipocyte diﬀerentiation is known to be inhibited by lithium
[4] and it has recently been reported that this occurs via the
activation of the Wnt pathway [5]. It is not clear how this eﬀect
is related to disturbances in adipose tissue accumulation in
lithium-treated patients. Increased adiposity is usually a sec-
ondary eﬀect of drugs that promote rather than inhibit adipo-
cyte diﬀerentiation, such as the antidiabetic peroxisome
proliferator activated receptor c (PPARc) activators the thia-
zolidinediones [6].
Whereas white adipocytes are the predominant cell type in
adipose tissue of adult humans, some brown adipocytes are
known to remain interspersed in adipose tissue depots of adult
humans. In some pathological conditions, such as phaeo-
chromocytoma or lipomatosis associated with the antiretrovi-
ral treatment of HIV infected patients, adults develop depots
of brown adipose tissue formed from newly developed brown
adipocytes [7,8]. Moreover, a reduced brown adipose pheno-
type in adipose tissue of adults is associated with metabolic
disturbances such as insulin resistance [9]. Brown adipocytes
play an opposite role to that of white adipocytes, and instead
of storing energy in the form of triacylglycerols, they burn met-
abolic substrates due to their high mitochondria content and
their naturally uncoupled mitochondrial respiratory chain.
The unique presence of uncoupling protein 1 (UCP-1) in
brown adipocyte mitochondria is responsible for energy expen-
diture in this cell type [10].
The speciﬁc eﬀects of lithium on brown adipocytes have not
been explored to date, and may account for some of the overall
eﬀects of lithium treatment on energy balance. Therefore, in
this study we have analysed the eﬀects of lithium on brown adi-
pocyte diﬀerentiation and gene expression.2. Materials and methods
Brown preadipocytes were isolated from 3-week-old mice and diﬀer-
entiated as described elsewhere [11]. Lithium chloride or sodium chlo-
ride was added to the cultures at diﬀerent times during the
diﬀerentiation process (day 1, day 4, or day 7) and cell morphology
and gene expression was analysed on day 8, when control cells had
achieved full diﬀerentiation. When indicated, cells were exposed on
day 7 to 0.5 lM noradrenaline (NA) for 5 h or to 1 lM all-trans reti-
noic acid (RA) for 24 h. RNA was extracted using an aﬃnity column-
based method (Qiagen, Hilden, Germany) and analysed by Northern
blot according to previously reported methods [12]. Blots were hybri-
dised using the cDNAs for the fatty acid binding protein aP2 (aP2/
FABP) [13], PPARc [14], cytochrome c oxidase subunit II (COII)
[15] and subunit IV (COIV) (ATCC, Rokville, USA), UCP-1 [16],
PPARc coactivator-1a (PGC-1a) [17], PPARa [18], a genomic frag-
ment of mitochondrial DNA corresponding to the mitochondrialblished by Elsevier B.V. All rights reserved.
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The cDNA probes were labelled with 32P dCTP using the random oli-
gonucleotide priming method. Equal loading of Northern blots was
estimated by ethidium bromide staining of gels. Autoradiographs were
quantiﬁed by densitometry. Statistical analysis was performed using
the Students t test.3. Results and discussion
Brown adipocytes exposed to 5 or 25 mM LiCl when already
diﬀerentiated (day 7 of culture) did not show any eﬀect on
morphology 24 h later (see Fig. 1) or even after longer times
of exposure to lithium (data not shown). In contrast, marked
eﬀects were observed when lithium was added on day 4 of cul-
ture, the time at which brown preadipocytes had stopped pro-
liferating and were beginning to diﬀerentiate (see Fig. 1, left).
Cells that were exposed to 5 mM lithium from day 4 of culture
showed reduced diﬀerentiation on day 8 of culture, as indi-
cated by a reduced appearance of cells accumulating lipid
droplets. When lithium was added at a concentration of
25 mM, almost no cells accumulated lipids, and they retained
a ﬁbroblast-like morphology. A full suppression of the acqui-
sition of diﬀerentiated brown adipocyte morphology on day 8
of culture was observed when either 5 or 25 mM lithium was
present continually from the ﬁrst day of culture (Fig. 1).
Brown adipocyte diﬀerentiation can be considered as the re-
sult of an overlay of gene expression proﬁles. First, there is an
adipogenic program of diﬀerentiation common to white and
brown adipocytes that is based on the accumulation of triacyl-
glycerol stores. This is associated with the expression of geneticFig. 1. Eﬀects of lithium on brown adipocyte diﬀerentiation in primary cu
diﬀerentiating medium supplemented with 25 mM sodium chloride (NaCl) fro
(LiCl) added on day 1, day 4, or day 7 of culture. Photographs were taken on
at day 4 of culture, before diﬀerentiation. Magniﬁcation at 40·.markers of lipid accumulation, such as aP2/FABP, or of mas-
ter transcription factors of genes involved in lipid metabolism,
such as PPARc. The mRNA expression of these genes in
brown adipocyte cell cultures exposed to lithium paralleled
the eﬀects on morphology. No eﬀects were found when lithium
was added to brown adipocytes on day 7, when the cells are
already diﬀerentiated (data not shown). Exposure to 5 mM
lithium from day 4 of culture lowered aP2/FABP and PPARc
mRNA levels whilst these transcripts became undetectable
when cells were exposed to 25 mM lithium. 5 mM lithium from
day 1 to day 8 led to lower but still detectable levels of aP2/
FABP and PPARc mRNAs whereas 25 mM lithium resulted
in undetectable levels of both transcripts. These eﬀects were
speciﬁc for the marker genes studied because, together with
the unaltered RNA loading shown in Fig. 2, the levels of the
2.2 kb mRNA for b-actin, a gene unrelated to adipocyte diﬀer-
entiation, were not modiﬁed by any treatment with lithium
(not shown).
A second aspect of the acquisition of the pattern of diﬀeren-
tiation of brown adipocytes is mitochondrial biogenesis [12].
This can be followed based on the expression of genes involved
in the respiratory chain/oxidative phosphorylation machinery
that are encoded by mitochondrial DNA (e.g., COII mRNA
or 16S ribosomal RNA) or by the nuclear genome (e.g., COIV
mRNA). Lithium treatment decreased the expression of these
marker genes but to a lesser extent than the adipogenic mark-
ers. There was a dose- and time-dependent reduction in the lev-
els of the mitochondrial DNA-encoded transcripts COII
mRNA and 16S rRNA, as well as in COIV mRNA, the reduc-
tion being more marked in the latter case. None of the lithiumltures. Brown adipocyte precursor cells were cultured for 8 days in
m day 1 of culture (control) or with either 5 or 25 mM lithium chloride
day 8 of culture with the exception of control cells that are also shown
Fig. 2. Eﬀects of lithium on gene expression in brown adipocytes diﬀerentiating in culture. Brown adipocyte precursor cells were cultured for 8 days
in diﬀerentiating medium supplemented with 25 mM sodium chloride from day 4 of culture (control) or with either 5 or 25 mM lithium chloride
added on day 1 (8 day lithium exposure) or day 4 (4 day lithium exposure). Relative abundance of gene transcripts was determined by Northern blot
analysis of 25 lg RNA. (A) Bars indicate means ± S.E.M. of three independent experiments and are expressed as percentages relative to the mean
value in brown adipocytes cultured in diﬀerentiating medium plus NaCl which was set to 100 (arbitrary units). Statistically signiﬁcant diﬀerences
(P < 0.05) from the NaCl-treated group are indicated by asterisks (*). Nd: non-detectable. (B) Examples of representative Northern blots and
ethidium bromide staining of ribosomal RNAs.
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scripts.
The diﬀerentiation of brown adipocytes also has speciﬁc fea-
tures that are diﬀerent from white adipocyte diﬀerentiation and
are functionally related to the diﬀerential thermogenic role of
this cell type. These include the expression of the mRNAs
for UCP-1, the mitochondrial uncoupling protein of brown
fat, PGC-1a, a transcriptional co-activator involved in the
acquisition of the several features of the diﬀerential brown adi-
pocyte phenotype [17], and by the enhanced expression of
PPARa, a subtype of the PPAR family involved in the coordi-
nate regulation of lipid catabolism genes that is expressed pref-
erentially in brown versus white adipocytes [21]. Lithium
dramatically inhibited the expression of these genes. Exposure
to lithium suppressed UCP-1 gene expression and UCP-1
mRNA became undetectable at any concentration or time of
exposure to lithium (see Fig. 2A), with the exception of 24 h
exposure in cells that were already diﬀerentiated cells, when
no eﬀect was observed (not shown). Exposure to 25 mM lith-
ium from day 4 of culture, or to any lithium concentration
from day 1 onwards also led to undetectable expression levels
of PGC-1a and PPARa transcripts. PGC-1a and PPARa
mRNAs were only detectable, although dramatically dimin-
ished, in cells exposed to 5 mM lithium from day 4 of culture.
In order to further explore the action of lithium on the spe-
ciﬁc functions of the brown adipocyte, on day 7 of culture cells
that had been exposed to lithium at diﬀerent points in the dif-
ferentiation process were treated with NA or RA, known acti-
vators of the brown adipocyte-speciﬁc gene UCP-1 (Fig. 3).
Cells exposed to either 5 or 25 mM lithium from day 1 did
not show any induction of UCP-1 gene expression in response
to these factors, and UCP-1 mRNA levels remained undetect-
able (data not shown). When lithium was added from day 4 of
culture, 25 mM lithium was completely non-permissive for
UCP-1 gene expression in response to either NA or RA.
UCP-1 mRNA expression was only induced in response to
NA or RA in cells treated with 5 mM lithium from day 4,
but to a much lesser extent than in control cells. Finally, cellsFig. 3. Eﬀects of noradrenaline and retinoic acid on UCP-1 gene expression i
Brown adipocyte precursor cells were cultured for 8 days in diﬀerentiating me
(control) or with either 5 or 25 mM lithium chloride that was added on day
were exposed to 0.5 lM noradrenaline (NA) for 5 h or 1 lM all-trans RA
Northern blot analysis of 25 lg RNA. Bars are means ± S.E.M. of three ind
point of maximum value, which was set to 100 (arbitrary units). Statistically
RA-treated cells for each culture condition are indicated by *, and those betw
lithium-exposed cells by #. Nd: non-detectable.that were treated with lithium for 24 h when already diﬀeren-
tiated (1 day treatment on day 7), showed not only unaltered
UCP-1 mRNA levels under basal conditions but also unaltered
expression in response to NA or RA compared with control
cells, either at 5 or 25 mM lithium concentration.
We conclude that lithium has an inhibitory eﬀect on all as-
pects of brown adipocyte diﬀerentiation that are common to
white adipocyte diﬀerentiation (lipid accumulation and marker
genes common to white and brown adipocytes). This is consis-
tent with studies using cell line models of white adipocyte dif-
ferentiation, in which an inhibitory eﬀect on overall
adipogenesis is attributed to the activation of Wnt signalling
by lithium [5]. However, the action of lithium was much more
powerful on marker genes speciﬁc to brown fat, and concen-
trations or times of exposure to lithium capable of maintaining
some expression of genes common to white and brown fat,
completely suppressed the expression of marker genes speciﬁc
to brown adipocytes. This strong inhibitory eﬀect could not be
counter-acted by addition of NA or RA, the most powerful
activators of the brown adipocyte-speciﬁc gene UCP-1. How-
ever, the inhibitory action of lithium was unequivocally associ-
ated with diﬀerentiation, and, when brown adipocytes had
already diﬀerentiated, lithium was no longer capable of inter-
fering with the basal expression of brown adipocyte-speciﬁc
genes or in the distinct intracellular pathways mediating
responsiveness to NA or RA. This indicates that lithium aﬀects
the speciﬁc program of brown adipocyte diﬀerentiation
rather than the intracellular pathways that enhance UCP-1
gene expression in brown fat cells once they are already
diﬀerentiated.
Considering that activation of the Wnt pathway appears to
be one of the principal mechanisms of action of lithium in adi-
pose cells, the present ﬁndings are consistent with recent re-
ports indicating that overexpression of Wnt-10b in adipose
tissues of transgenic mice leads to a complete suppression of
marker gene expression speciﬁc to brown adipocytes, i.e.,
UCP-1, in anatomical depots of brown adipose tissue, whereas
white adipose tissue gene expression is maintained. This isn brown adipocytes diﬀerentiating in culture in the presence of lithium.
dium supplemented with 25 mM sodium chloride from day 4 of culture
4 (4 day lithium exposure) or on day 7 (1 day lithium exposure). Cells
for 24 h. Relative abundance of UCP-1 mRNA was determined by
ependent experiments and are expressed as percentages relative to the
signiﬁcant diﬀerences (P < 0.05) between the controls and the NA or
een control cells exposed to NA or RA and the equivalent treatments in
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sponse to food intake, and cold intolerance, indicative of im-
paired brown adipose tissue function [22].
In summary, these results indicate that, although lithium has
suppressive eﬀects on overall adipocyte diﬀerentiation, brown
adipocytes are particularly sensitive to this eﬀect. A particu-
larly intense inhibition of brown adipocyte expression patterns
in response to lithium could explain the preferential eﬀects of
lithium in inhibiting energy expenditure and therefore promot-
ing weight gain. The potential diﬀerences between white and
brown adipocytes in their cellular responsiveness to Wnt or
other pathways that may be involved in lithium eﬀects are un-
known, and deserve further research to explain the high sensi-
tivity of brown adipocytes to lithium eﬀects.
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